1. Home
  2. RYTM vs CWST Comparison

RYTM vs CWST Comparison

Compare RYTM & CWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

N/A

Current Price

$97.07

Market Cap

5.8B

Sector

Health Care

ML Signal

N/A

Logo Casella Waste Systems Inc.

CWST

Casella Waste Systems Inc.

N/A

Current Price

$90.47

Market Cap

6.4B

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
RYTM
CWST
Founded
2008
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Environmental Services
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.4B
IPO Year
2017
1997

Fundamental Metrics

Financial Performance
Metric
RYTM
CWST
Price
$97.07
$90.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
7
Target Price
$131.14
$115.71
AVG Volume (30 Days)
421.1K
375.9K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
28.34
N/A
EPS
N/A
N/A
Revenue
N/A
$1,836,841,000.00
Revenue This Year
$55.34
$10.95
Revenue Next Year
$86.06
$6.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.95
52 Week Low
$74.50
$74.05
52 Week High
$122.20
$107.96

Technical Indicators

Market Signals
Indicator
RYTM
CWST
Relative Strength Index (RSI) 40.64 46.51
Support Level $99.14 $88.45
Resistance Level $113.04 $94.72
Average True Range (ATR) 3.98 2.40
MACD -0.78 -0.37
Stochastic Oscillator 19.75 33.02

Price Performance

Historical Comparison
RYTM
CWST

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

About CWST Casella Waste Systems Inc.

Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.

Share on Social Networks: